Psychiatric Complications with Chloroquine and Quinacrine
Abstract
Quinacrine and chloroquine are being used increasingly in the United States in the treatment of malaria and as an anti-inflammatory agent. In the two cases reported here, quinacrine was administered within the normal therapeutic range and toxic psychoses resulted. Chloroquine produces similar conditions. The author predicts an increase in the complications of suicide, malingering, and toxic psychoses associated with the increasing use of the two drugs.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).